"Lupus Nephritis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).
| Descriptor ID |
D008181
|
| MeSH Number(s) |
C12.777.419.570.363.680 C13.351.968.419.570.363.680 C17.300.480.680 C20.111.590.560
|
| Concept/Terms |
Lupus Nephritis- Lupus Nephritis
- Lupus Glomerulonephritis
- Nephritis, Lupus
- Lupus Nephritides
- Nephritides, Lupus
- Glomerulonephritis, Lupus
- Glomerulonephritides, Lupus
- Lupus Glomerulonephritides
|
Below are MeSH descriptors whose meaning is more general than "Lupus Nephritis".
Below are MeSH descriptors whose meaning is more specific than "Lupus Nephritis".
This graph shows the total number of publications written about "Lupus Nephritis" by people in this website by year, and whether "Lupus Nephritis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 5 | 1 | 6 |
| 1997 | 1 | 3 | 4 |
| 1998 | 3 | 1 | 4 |
| 1999 | 4 | 3 | 7 |
| 2000 | 0 | 2 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 4 | 2 | 6 |
| 2004 | 1 | 1 | 2 |
| 2005 | 4 | 1 | 5 |
| 2006 | 4 | 0 | 4 |
| 2007 | 4 | 0 | 4 |
| 2008 | 6 | 1 | 7 |
| 2009 | 2 | 3 | 5 |
| 2010 | 6 | 3 | 9 |
| 2011 | 5 | 1 | 6 |
| 2012 | 3 | 3 | 6 |
| 2013 | 4 | 0 | 4 |
| 2014 | 7 | 1 | 8 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 2 | 5 |
| 2019 | 2 | 0 | 2 |
| 2020 | 4 | 0 | 4 |
| 2021 | 7 | 0 | 7 |
| 2022 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lupus Nephritis" by people in Profiles.
-
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership. Rheumatology (Oxford). 2022 11 02; 61(11):4335-4343.
-
Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium study. Pediatr Nephrol. 2022 Dec; 37(12):3139-3145.
-
Endothelial cells: potential novel regulators of renal inflammation. Am J Physiol Renal Physiol. 2022 03 01; 322(3):F309-F321.
-
Mesangial Cells in Lupus Nephritis. Curr Rheumatol Rep. 2022 01 05; 23(12):83.
-
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis. Arthritis Rheumatol. 2022 02; 74(2):263-273.
-
Prediction models of treatment response in lupus nephritis. Kidney Int. 2022 02; 101(2):379-389.
-
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE. Pediatr Rheumatol Online J. 2021 Aug 30; 19(1):137.
-
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network. Lupus Sci Med. 2021 08; 8(1).
-
Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis. Lupus Sci Med. 2021 08; 8(1).
-
Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB ? NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis Rheumatol. 2021 08; 73(8):1478-1488.